- $15.47bn
- $14.68bn
- $12.58bn
- 99
- 37
- 99
- 92
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,175 | 8,797 | 9,904 | 11,076 | 12,583 |
Cost of Revenue | |||||
Gross Profit | 1,356 | 1,395 | 1,502 | 1,604 | 2,089 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8,714 | 8,540 | 9,373 | 10,511 | 11,707 |
Operating Profit | 461 | 257 | 531 | 565 | 876 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 451 | 252 | 529 | 559 | 873 |
Provision for Income Taxes | |||||
Net Income After Taxes | 325 | 133 | 384 | 406 | 633 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 325 | 133 | 384 | 406 | 633 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 325 | 133 | 384 | 406 | 633 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.77 | 4.66 | 7.16 | 8.02 | 13.3 |
Dividends per Share |